Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Maternal Neglect (OT-MOM)
NCT02737436Completed
- Sponsor
- Baylor College of Medicine
- Start
- May 2010
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Blood Oxygen Level Dependent Signal in Dopamine Reward Regions and Prefrontal Cortex at 30 minutes. Started May 2010; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT02737436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737436.